Skin Cancer Breakthrough: Arthritis Drug Could Be New Weapon Against Melanoma

Featured Article
Academic Journal
Main Category: Melanoma / Skin Cancer
Also Included In: Cancer / Oncology;  Arthritis / Rheumatology;  Dermatology
Article Date: 24 Mar 2011 – 13:00 PDT

email icon email to a friend   printer icon printer friendly   write icon opinions  
<!– rate icon rate article

Patient / Public:4 and a half stars

4.4 (5 votes)

Healthcare Prof:5 stars

5 (1 votes)

Leflunomide, a drug commonly used to treat rheumatoid arthritis, may also inhibit the growth of malignant melanoma, a
deadly form of skin cancer, according to new research led by the University of East Anglia (UAE) in the UK and Children’s
Hospital Boston in the US.

Krystal Knight To Join Medicare Rights Center As State Program And Policy Coordinator

Main Category: Medicare / Medicaid / SCHIP
Article Date: 25 Mar 2011 – 11:00 PDT

email icon email to a friend   printer icon printer friendly   write icon opinions  
<!– rate icon rate article

Patient / Public:not yet rated

Healthcare Prof:not yet rated

Krystal Knight, M.P.H., will join the Medicare Rights Center’s Washington, D.C. office to serve in the newly created position of State Program and Policy Coordinator. Ms. Knight will oversee a new project funded by Atlantic Philanthropies to expand the Medicare Rights Center’s community-based education and policy programs in five states-Alabama, Florida, Kansas, Maine and Wisconsin.

New Guide Aims To Help Long-Term Care Facilities Deliver Medicare Skilled Services

Main Category: Medicare / Medicaid / SCHIP
Article Date: 26 Mar 2011 – 0:00 PDT

email icon email to a friend   printer icon printer friendly   write icon opinions  
<!– rate icon rate article

Patient / Public:not yet rated

Healthcare Prof:not yet rated

Deciding when a resident is eligible to move to skilled care ranks among the most challenging dilemmas for long-term care facilities. Tracking Medicare Part A admissions rules, MDS assessments, eligibility requirements and benefits periods can stymie even the most careful administrators and clinicians — and negatively impact reimbursements, which can average from $350 to $650 per day for each Medicare resident.

Long-Term Safety Data Demonstrated Vimovotm Is Generally Well Tolerated In Arthritis Patients At Risk For NSAID-Associated Gastric Ulcers

Main Category: Arthritis / Rheumatology
Also Included In: GastroIntestinal / Gastroenterology;  Pain / Anesthetics
Article Date: 25 Mar 2011 – 1:00 PDT

email icon email to a friend   printer icon printer friendly   write icon opinions  
<!– rate icon rate article



Patient / Public:not yet rated

Healthcare Prof:not yet rated

AstraZeneca (NYSE: AZN) today announced results from PN400-304, a long-term safety study of VIMOVO™ (naproxen/esomeprazole magnesium) 500/20 mg delayed-release tablets in osteoarthritis patients requiring daily nonsteroidal anti-inflammatory drug (NSAID) therapy who were at risk for NSAID-associated gastric ulcers.[3] The data demonstrated VIMOVO was generally well tolerated throughout the 12-month treatment period, with no new or unexpected safety issues.1 Study findings were presented at the American Academy of Pain Medicine (AAPM) Annual Meeting in National Harbor, MD, and published in Current Medical Research and Opinion, the international, peer reviewed clinical research journal.[4]

Largest-Ever Biopsy Study In Osteoporosis Demonstrates Superior Bone Forming Activity With Protelos(R) (Strontium Ranelate) Versus Bisphosphonates

Main Category: Bones / Orthopedics
Also Included In: Menopause;  Arthritis / Rheumatology
Article Date: 25 Mar 2011 – 4:00 PDT

email icon email to a friend   printer icon printer friendly   write icon opinions  
<!– rate icon rate article



Patient / Public:4 stars

4 (1 votes)

Healthcare Prof:not yet rated

Protelos® (strontium ranelate) has significantly greater bone-forming activity than the commonly prescribed bisphosphonate, alendronate, according to results of the largest-ever biopsy study in post-menopausal women presented at the European Congress on Osteoporosis and Osteoarthritis (ECCEO011-IOF) in Valencia. (i) Through its unique dual impact on both bone formation and resorption, Protelos substantially reduces fracture risk, the primary goal of osteoporosis treatment.

61% Of Seniors Surveyed Think Health Care Reform Bill Weakens Medicare; Yet 57% Will Take Advantage Of Free Physical Exam Included In Bill

Main Category: Medicare / Medicaid / SCHIP
Also Included In: Seniors / Aging
Article Date: 23 Mar 2011 – 9:00 PDT

email icon email to a friend   printer icon printer friendly   write icon opinions  
<!– rate icon rate article

Patient / Public:not yet rated

Healthcare Prof:not yet rated

On the eve of the one-year anniversary of the health care reform bill, a survey of 321 seniors 65 and older revealed that 61%1 think the bill has weakened Medicare in the year since it became law. At the same time, 57% of those surveyed say they will take advantage of a free physical exam and personal wellness plan benefit included in the bill that went into effect this year.

Nearly 4 Million Medicare Beneficiaries Receive Help With Prescription Drug Cost Under Affordable Care Act

Main Category: Medicare / Medicaid / SCHIP
Article Date: 23 Mar 2011 – 9:00 PDT

email icon email to a friend   printer icon printer friendly   write icon opinions  
<!– rate icon rate article

Patient / Public:not yet rated

Healthcare Prof:not yet rated

Through provisions of the Affordable Care Act, nearly 4 million people with Medicare who reached the program’s Part D coverage gap in 2010 have received a one-time, tax-free $250 rebate check. U.S. Department of Health and Human Services Secretary Kathleen Sebelius announced today that a similar number of Medicare beneficiaries are likely to enter the coverage gap in 2011 and will benefit from additional Affordable Care Act provisions that work to reduce and close the “donut hole” by 2020. Already, nearly 48,000 Medicare enrollees have saved $38 million – an average of $800 per person – thanks to a new 50-percent discount on covered brand-name drugs in the donut hole.

Exploring New Treatments To End Osteoarthritis

Main Category: Arthritis / Rheumatology
Also Included In: Obesity / Weight Loss / Fitness;  Seniors / Aging;  Conferences
Article Date: 24 Mar 2011 – 4:00 PDT

email icon email to a friend   printer icon printer friendly   write icon opinions  
<!– rate icon rate article



Patient / Public:not yet rated

Healthcare Prof:not yet rated

Arthritis researchers from North America and Europe will convene in Chicago this week to present new osteoarthritis research that could lead to better ways to detect, treat, prevent and cure osteoarthritis (OA), which affects 27 million Americans. Hosted by the Arthritis Foundation, the Segal North American Osteoarthritis Workshop (SNOW) on March 25-27 will focus on specific forms of OA, such as those that follow joint trauma, obesity and the aging process.

Medicare Locals

Main Category: Medicare / Medicaid / SCHIP
Article Date: 24 Mar 2011 – 2:00 PDT

email icon email to a friend   printer icon printer friendly   write icon opinions  
<!– rate icon rate article

Patient / Public:not yet rated

Healthcare Prof:not yet rated

The AMA today released its Position Statement on Medicare Locals and urged the Government to adopt the AMA recommendations to establish better primary health care organisations (PHCOs) than the currently proposed Medicare Locals model.

AMA President, Dr Andrew Pesce, said today that the main function of Medicare Locals must be to better support the role of the GP in delivering services to patients.

Health Care Reform, Deficit Reduction Proposals, And Repeal Efforts And Their Effect On The Medicare Program

Main Category: Medicare / Medicaid / SCHIP
Also Included In: Health Insurance / Medical Insurance
Article Date: 24 Mar 2011 – 6:00 PDT

email icon email to a friend   printer icon printer friendly   write icon opinions  
<!– rate icon rate article

Patient / Public:not yet rated

Healthcare Prof:not yet rated

One year ago, on March 23, 2010, President Obama signed into law the Patient Protection and Affordable Care Act, the Health Care Reform law[1] that will provide access to health insurance for virtually all Americans.